Literature DB >> 31727766

CD34+ acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness genes and can be targeted by the BCL2 inhibitor venetoclax.

Katharina Mattes1, Mylène Gerritsen1, Hendrik Folkerts1, Marjan Geugien1, Fiona A van den Heuvel1, Arthur Flohr Svendsen2, Guoqiang Yi3, Joost H A Martens3, Edo Vellenga4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31727766      PMCID： PMC7395293          DOI： 10.3324/haematol.2019.229997

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.

Authors:  Marina Konopleva; Rooha Contractor; Twee Tsao; Ismael Samudio; Peter P Ruvolo; Shinichi Kitada; Xingming Deng; Dayong Zhai; Yue-Xi Shi; Thomas Sneed; Monique Verhaegen; Maria Soengas; Vivian R Ruvolo; Teresa McQueen; Wendy D Schober; Julie C Watt; Tilahun Jiffar; Xiaoyang Ling; Frank C Marini; David Harris; Martin Dietrich; Zeev Estrov; James McCubrey; W Stratford May; John C Reed; Michael Andreeff
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

2.  SRC-3 is involved in maintaining hematopoietic stem cell quiescence by regulation of mitochondrial metabolism in mice.

Authors:  Mengjia Hu; Hao Zeng; Shilei Chen; Yang Xu; Song Wang; Yong Tang; Xinmiao Wang; Changhong Du; Mingqiang Shen; Fang Chen; Mo Chen; Cheng Wang; Jining Gao; Fengchao Wang; Yongping Su; Junping Wang
Journal:  Blood       Date:  2018-06-29       Impact factor: 22.113

3.  Meis1 preserves hematopoietic stem cells in mice by limiting oxidative stress.

Authors:  Zeenath Unnisa; Jason P Clark; Jayeeta Roychoudhury; Elizabeth Thomas; Lino Tessarollo; Neal G Copeland; Nancy A Jenkins; H Leighton Grimes; Ashish R Kumar
Journal:  Blood       Date:  2012-10-22       Impact factor: 22.113

4.  P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.

Authors:  D M van der Kolk; E G de Vries; W J van Putten; L F Verdonck; G J Ossenkoppele; G E Verhoef; E Vellenga
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

5.  Tracing the origins of relapse in acute myeloid leukaemia to stem cells.

Authors:  Liran I Shlush; Amanda Mitchell; Lawrence Heisler; Sagi Abelson; Stanley W K Ng; Aaron Trotman-Grant; Jessie J F Medeiros; Abilasha Rao-Bhatia; Ivana Jaciw-Zurakowsky; Rene Marke; Jessica L McLeod; Monica Doedens; Gary Bader; Veronique Voisin; ChangJiang Xu; John D McPherson; Thomas J Hudson; Jean C Y Wang; Mark D Minden; John E Dick
Journal:  Nature       Date:  2017-06-28       Impact factor: 49.962

6.  AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells.

Authors:  Shanshan Pei; Mohammad Minhajuddin; Biniam Adane; Nabilah Khan; Brett M Stevens; Stephen C Mack; Sisi Lai; Jeremy N Rich; Anagha Inguva; Kevin M Shannon; Hyunmin Kim; Aik-Choon Tan; Jason R Myers; John M Ashton; Tobias Neff; Daniel A Pollyea; Clayton A Smith; Craig T Jordan
Journal:  Cell Stem Cell       Date:  2018-06-14       Impact factor: 24.633

Review 7.  Stem cells and the impact of ROS signaling.

Authors:  Carolina L Bigarella; Raymond Liang; Saghi Ghaffari
Journal:  Development       Date:  2014-11       Impact factor: 6.868

8.  A parsimonious 3-gene signature predicts clinical outcomes in an acute myeloid leukemia multicohort study.

Authors:  Sarah Wagner; Jayakumar Vadakekolathu; Sarah K Tasian; Heidi Altmann; Martin Bornhäuser; A Graham Pockley; Graham R Ball; Sergio Rutella
Journal:  Blood Adv       Date:  2019-04-23

9.  Id1 Ablation Protects Hematopoietic Stem Cells from Stress-Induced Exhaustion and Aging.

Authors:  Satyendra K Singh; Shweta Singh; Stephen Gadomski; Lei Sun; Alexander Pfannenstein; Valentin Magidson; Xiongfong Chen; Serguei Kozlov; Lino Tessarollo; Kimberly D Klarmann; Jonathan R Keller
Journal:  Cell Stem Cell       Date:  2018-06-28       Impact factor: 24.633

10.  Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma.

Authors:  Rishu Agarwal; Yih-Chih Chan; Constantine S Tam; Tane Hunter; Dane Vassiliadis; Charis E Teh; Rachel Thijssen; Paul Yeh; Stephen Q Wong; Sarah Ftouni; Enid Y N Lam; Mary Ann Anderson; Christiane Pott; Omer Gilan; Charles C Bell; Kathy Knezevic; Piers Blombery; Kathleen Rayeroux; Adrian Zordan; Jason Li; David C S Huang; Meaghan Wall; John F Seymour; Daniel H D Gray; Andrew W Roberts; Mark A Dawson; Sarah-Jane Dawson
Journal:  Nat Med       Date:  2018-11-19       Impact factor: 53.440
View more
  3 in total

1.  Recruiting TP53 to target chronic myeloid leukemia stem cells.

Authors:  Steven Grant
Journal:  Haematologica       Date:  2020-05       Impact factor: 11.047

Review 2.  A narrative review of central nervous system involvement in acute leukemias.

Authors:  Dalma Deak; Nicolae Gorcea-Andronic; Valentina Sas; Patric Teodorescu; Catalin Constantinescu; Sabina Iluta; Sergiu Pasca; Ionut Hotea; Cristina Turcas; Vlad Moisoiu; Alina-Andreea Zimta; Simona Galdean; Jakob Steinheber; Ioana Rus; Sebastian Rauch; Cedric Richlitzki; Raluca Munteanu; Ancuta Jurj; Bobe Petrushev; Cristina Selicean; Mirela Marian; Olga Soritau; Alexandra Andries; Andrei Roman; Delia Dima; Alina Tanase; Olafur Sigurjonsson; Ciprian Tomuleasa
Journal:  Ann Transl Med       Date:  2021-01

Review 3.  Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.

Authors:  Yammy Yung; Emily Lee; Hiu-Tung Chu; Pui-Kwan Yip; Harinder Gill
Journal:  Int J Mol Sci       Date:  2021-01-11       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.